Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections

Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli

(2017) Jérôme Tourret et al.   TRANSPLANTATION

Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection

(2017) Vanessa W. Stevens et al.   JAMA Internal Medicine

Racial and ethnic disparities in health care–associated Clostridium difficile infections in the United States: State of the science

(2016) Sandra Yang et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Clostridium difficile infection health disparities by race among hospitalized adults in the United States, 2001 to 2010

(2016) Jacqueline R. Argamany et al.   BMC INFECTIOUS DISEASES

A Detrimental Role of Immunosuppressive Drug, Dexamethasone, During Clostridium difficile Infection in Association with a Gastrointestinal Microbial Shift

(2016) Hyeun Bum Kim et al.   JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY

Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients

(2013) Daniel E Freedberg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

(2013) Els van Nood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals

(2011) Becky A. Miller et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Intestinal homeostasis and its breakdown in inflammatory bowel disease

(2011) Kevin J. Maloy et al.   NATURE